Levonorgestrel/Ethinylestradiol Morningside Healthcare (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Levonorgestrel/Ethinylestradiol Morningside Healthcare, is a combined estrogen‑progestogen oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Levonorgestrel/Ethinylestradiol Morningside Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel/Ethinylestradiol is a combined oral contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy. - Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Management of androgen‑related acne: reduces sebum production and improves skin appearance.

Levonorgestrel/Ethinylestradiol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertension: new‑onset or worsening high blood pressure. - Hepatic adenoma: benign liver tumor. - Gallbladder disease: gallstones or cholecystitis. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden loss of vision or eye pain.

Before prescribing Levonorgestrel/Ethinylestradiol, clinicians should consider several safety factors. - Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk. - History of thrombosis: contraindicated in patients with prior venous or arterial clotting events. - Hypertension: monitor blood pressure regularly. - Liver disease: use with caution in active hepatic impairment. - Migraine with aura: avoid because of elevated stroke risk. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Levonorgestrel/Ethinylestradiol can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin and other antimycobacterial agents: decrease hormone levels. - Certain HIV protease inhibitors: may increase hormone concentrations.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may raise hormone levels. - St. John’s wort: potential reduction in effectiveness. - Antibiotics (e.g., tetracycline): generally no significant effect, but monitor for breakthrough bleeding.